These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1153 related items for PubMed ID: 17918088

  • 21. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection.
    Rodríguez-Méndez ML, González-Quintela A, Aguilera A, Barrio E.
    Am J Gastroenterol; 2000 May; 95(5):1316-22. PubMed ID: 10811346
    [Abstract] [Full Text] [Related]

  • 22. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A, Ergünay K, Calık Başaran N, Alp A, Turgut D, Hasçelik G, Uzun Ö, Unal S.
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [Abstract] [Full Text] [Related]

  • 23. Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: impact of compromised immunity.
    Sun HY, Lee HC, Liu CE, Yang CL, Su SC, Ko WC, Lin CY, Tsai JJ, Wong WW, Ho MW, Cheng SH, Lin YH, Miao WJ, Hung CC.
    J Viral Hepat; 2010 Aug; 17(8):578-87. PubMed ID: 19818002
    [Abstract] [Full Text] [Related]

  • 24. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H, Touré-Kane C, Etard JF, Lô G, Diaw P, Ngom-Gueye NF, Gueye PM, Ba-Fall K, Ndiaye I, Sow PS, Delaporte E, Mboup S.
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [Abstract] [Full Text] [Related]

  • 25. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E.
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [Abstract] [Full Text] [Related]

  • 26. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity.
    Haushofer AC, Hauer R, Brunner H, Köller U, Trubert-Exinger D, Halbmayer WM, Koidl C, Kessler HH.
    J Clin Virol; 2004 Apr; 29(4):221-3. PubMed ID: 15018848
    [Abstract] [Full Text] [Related]

  • 27. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
    Uhm JE, Kim K, Lim TK, Park BB, Park S, Hong YS, Lee SC, Hwang IG, Koh KC, Lee MH, Ahn JS, Kim WS, Jung CW, Kang WK.
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
    [Abstract] [Full Text] [Related]

  • 28. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [Abstract] [Full Text] [Related]

  • 29. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

  • 30. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY, Cho SH, Lee SM, Koh MB, Noh CH, Kim CW, Choi JY, Yang JM, Han JY, Lee YS.
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [Abstract] [Full Text] [Related]

  • 31. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [Abstract] [Full Text] [Related]

  • 32. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma.
    Matsue K, Kimura S, Takanashi Y, Iwama K, Fujiwara H, Yamakura M, Takeuchi M.
    Cancer; 2010 Oct 15; 116(20):4769-76. PubMed ID: 20597091
    [Abstract] [Full Text] [Related]

  • 33. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
    Pippi F, Bracciale L, Stolzuoli L, Giaccherini R, Montomoli E, Gentile C, Filetti S, De Luca A, Cellesi C.
    HIV Med; 2008 Aug 15; 9(7):519-25. PubMed ID: 18554311
    [Abstract] [Full Text] [Related]

  • 34. [Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells].
    Smit MC, Haverkamp MH, Weersink AJ, Boucher CA, Hoepelman IM.
    Ned Tijdschr Geneeskd; 2004 Nov 20; 148(47):2330-4. PubMed ID: 15587052
    [Abstract] [Full Text] [Related]

  • 35. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.
    Neau D, Winnock M, Galpérine T, Jouvencel AC, Castéra L, Legrand E, Tranchant E, Balestre E, Lacoste D, Ragnaud JM, Dupon M, Lafon ME, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    HIV Med; 2004 May 20; 5(3):171-3. PubMed ID: 15139983
    [Abstract] [Full Text] [Related]

  • 36. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.
    Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, de Wit S, Monforte Ad, Flisiak R, Lundgren J, EuroSIDA.
    J Antimicrob Chemother; 2010 Mar 20; 65(3):548-55. PubMed ID: 20051475
    [Abstract] [Full Text] [Related]

  • 37. HBV and HCV infection in Japanese dental care workers.
    Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.
    Int J Mol Med; 2008 Jun 20; 21(6):791-9. PubMed ID: 18506374
    [Abstract] [Full Text] [Related]

  • 38. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 20; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 39. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.
    Liver Transpl; 2001 Jan 20; 7(1):51-8. PubMed ID: 11150423
    [Abstract] [Full Text] [Related]

  • 40. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY, Ko WC, Tsai JJ, Lee HC, Liu CE, Wong WW, Su SC, Ho MW, Cheng SH, Yang CH, Lin YH, Miao WJ, Sheng WH, Hung CC.
    Am J Gastroenterol; 2009 Apr 20; 104(4):877-84. PubMed ID: 19259078
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.